The Immunological Basis for Treatment Resistance to Anti-TNF Treatments
Phase of Trial: Phase IV
Latest Information Update: 15 Jan 2019
Price : $35 *
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 06 Nov 2017 Status changed from recruiting to completed.
- 03 Feb 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018 as reported by ClinicalTrials.gov record.